Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2000
12/05/2000US6156038 Spine distraction implant and method
12/05/2000CA2195974C 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
12/05/2000CA2188066C Thio-substituted phosphonate compounds
12/05/2000CA2184365C Concentrated acetaminophen solution compositions
12/05/2000CA2184361C Solid dose forms containing bismuth
12/05/2000CA2181985C Modified-release metronidazole compositions and methods for making and using same
12/05/2000CA2136822C Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/05/2000CA2135179C Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
12/05/2000CA2085216C Tetrahydroisoquinolinylcarbamates of 1,2,3,3a,8,8a- hexahydro-1,3a,8-trimethylpyrrolo ¬2,3-b| indole
12/05/2000CA1341151C Osmotic agents form peritoneal dialysis
12/04/2000WO2000075103A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) $g(a)
12/04/2000CA2311112A1 Trovafloxacin oral suspensions
12/04/2000CA2310873A1 New arylpiperazinylalkyl-3 (2h)-pyridazinones
12/03/2000CA2273699A1 New uses of oubain and oubain-like molecules in apoptosis related pathologies
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000072008A2 Identification of novel mechanisms of drug resistance
11/30/2000WO2000071754A1 Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors
11/30/2000WO2000071752A2 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000WO2000071740A1 High specificity hairpin antisense oligonucleotides
11/30/2000WO2000071737A2 Improved retroviral production by inhibition of the enveloppe cell receptor
11/30/2000WO2000071736A1 Isoflavonoid methylation enzyme
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071706A1 ANTISENSE TO c-myc FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
11/30/2000WO2000071703A2 Inhibition of histone deacetylase
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071571A2 Fap-activated anti-tumor compounds
11/30/2000WO2000071563A2 Taccalonolide microtubule stabilizing agents
11/30/2000WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071558A1 Orally active a1 adenosine receptor agonists
11/30/2000WO2000071557A1 13-methyl-erythromycin derivatives
11/30/2000WO2000071556A1 Prodrug activation using catalytic antibodies
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071543A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000WO2000071541A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
11/30/2000WO2000071540A1 Hydrochloride of fused-heterocycle compound
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071534A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents
11/30/2000WO2000071532A1 Heterocyclic derivatives useful as anticancer agents
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071524A1 2-nh-pyridones and pyrimidones as mrs inhibitors
11/30/2000WO2000071523A1 Antibiotic prodrugs
11/30/2000WO2000071522A1 Benzimidazole derivatives and their use as methionyl t-rna synthetase inhibitors
11/30/2000WO2000071520A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000071516A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071515A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071513A1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
11/30/2000WO2000071512A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071511A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071510A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071509A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071508A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071507A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071506A2 Naphthalene ureas as glucose uptake enhancers
11/30/2000WO2000071493A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071424A1 Method and apparatus for distributing powder
11/30/2000WO2000071419A1 Method and apparatus for loading a container with a product
11/30/2000WO2000071165A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues
11/30/2000WO2000071163A1 Emulsion vehicle for poorly soluble drugs
11/30/2000WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY
11/30/2000WO2000071153A2 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071146A2 Glutathione reductase for therapy and prophylaxis of aids
11/30/2000WO2000071144A1 Prolyl endopeptidase inhibitor
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071137A1 Electrolyte gels for maintaining hydration and rehydration
11/30/2000WO2000071136A1 Adhesive n,o-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
11/30/2000WO2000071135A1 Anti-tumor comprising boroproline compounds
11/30/2000WO2000071134A1 Isophosphoramide mustard analogs and use thereof
11/30/2000WO2000071132A1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
11/30/2000WO2000071129A1 Pyrrolotriazine inhibitors of kinases
11/30/2000WO2000071128A1 Compositions and method for decreasing neuropathic pain
11/30/2000WO2000071127A1 Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
11/30/2000WO2000071126A1 Quinoxaline containing medicaments for post exposure prophylaxis of an hiv infection
11/30/2000WO2000071125A2 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction
11/30/2000WO2000071124A1 Amorphous form of fexofenadine hydrochloride
11/30/2000WO2000071123A1 New anti-sickling agents: selection methods and effective compounds
11/30/2000WO2000071122A1 Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
11/30/2000WO2000071121A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
11/30/2000WO2000071120A1 Antibacterial compounds
11/30/2000WO2000071119A1 Mag expression promoters
11/30/2000WO2000071118A1 Phospholipase a2-specific inhibiting compounds
11/30/2000WO2000071117A1 Immediate release medicinal compositions for oral use
11/30/2000WO2000071115A1 Antihypertensive compound from caesalpinia brasiliensis
11/30/2000WO2000071114A1 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate]
11/30/2000WO2000071113A1 Methods of treating proliferative disorders
11/30/2000WO2000071112A1 Therapeutic uses for nitric oxide inhibitors
11/30/2000WO2000071111A1 Stimulating transport of glucose into animal tissue by the administration of pinitol
11/30/2000WO2000071110A1 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
11/30/2000WO2000071109A2 Pharmaceutical compositions comprising s-(+) -desmethylselegiline for the treatment of withdrawal
11/30/2000WO2000071108A2 Methods for treatment of asthma using s-oxybutynin
11/30/2000WO2000071107A2 New pharmaceutical combinations for nos inhibitors
11/30/2000WO2000071106A2 Method of treating weight gain
11/30/2000WO2000071105A2 Tricloroacetic acid for the preparation of solutions and/or compositions for the treatment of erosive and/or ulcerative lesions
1 ... 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 ... 7860